Market Tracker

06/23 5:16pm ET

Emergent BioSolutions Inc (NYSE:EBS)

34.65
Delayed Data
As of Jun 23
 +0.71 / +2.09%
Today’s Change
24.47
Today|||52-Week Range
36.64
+5.51%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close33.94
Today’s open33.93
Day’s range33.37 - 34.75
Volume847,092
Average volume (3 months)323,194
Market cap$1.4B
Dividend yield--
Data as of 4:07pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+1.73%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio26.5
Price/Sales3.31
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.24+1.89%
CORTCorcept Therapeutics...+0.44+3.64%
FOLDAmicus Therapeutics ...+0.35+3.47%
RGENRepligen Corp+4.11+10.25%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts